Home Healthcare Medical Devices Autoinjectors Market

Autoinjectors Market Size, Share & Trends Analysis Report By Product Type (Disposable Autoinjectors, Reusable Autoinjectors), By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies), By End Use (Homecare Settings, Hospitals & Clinics, Ambulatory Surgical Centers) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format: | Report Code: SR276DR | Pages: 170
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Autoinjectors Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Disposable Autoinjectors
    2. Reusable Autoinjectors
  2. Autoinjectors Market, By Indication  2022-2034 (USD MILLION/ Units)
    1. Rheumatoid Arthritis
    2. Multiple Sclerosis
    3. Diabetes
    4. Anaphylaxis
    5. Other Therapies
  3. Autoinjectors Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Homecare Settings
    2. Hospitals & Clinics
    3. Ambulatory Surgical Centers
  4. Regional Autoinjectors Market
    1. North America
      1. North America Autoinjectors Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
      2. North America Autoinjectors Market By Indication  2022-2034 (USD MILLION/ Units)
        1. Rheumatoid Arthritis
        2. Multiple Sclerosis
        3. Diabetes
        4. Anaphylaxis
        5. Other Therapies
      3. North America Autoinjectors Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Ambulatory Surgical Centers
      4. U.S.
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      5. Canada
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
    2. Europe
      1. Europe Autoinjectors Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
      2. Europe Autoinjectors Market By Indication  2022-2034 (USD MILLION/ Units)
        1. Rheumatoid Arthritis
        2. Multiple Sclerosis
        3. Diabetes
        4. Anaphylaxis
        5. Other Therapies
      3. Europe Autoinjectors Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Ambulatory Surgical Centers
      4. U.K.
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      5. Germany
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      6. France
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      7. Spain
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      8. Italy
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      9. Russia
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      10. Nordic
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      11. Benelux
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      12. Rest of Europe
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
    3. APAC
      1. APAC Autoinjectors Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
      2. APAC Autoinjectors Market By Indication  2022-2034 (USD MILLION/ Units)
        1. Rheumatoid Arthritis
        2. Multiple Sclerosis
        3. Diabetes
        4. Anaphylaxis
        5. Other Therapies
      3. APAC Autoinjectors Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Ambulatory Surgical Centers
      4. China
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      5. Korea
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      6. Japan
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      7. India
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      8. Australia
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      9. Taiwan
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      10. South East Asia
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      11. Rest of Asia-Pacific
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
    4. Middle East and Africa
      1. Middle East and Africa Autoinjectors Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
      2. Middle East and Africa Autoinjectors Market By Indication  2022-2034 (USD MILLION/ Units)
        1. Rheumatoid Arthritis
        2. Multiple Sclerosis
        3. Diabetes
        4. Anaphylaxis
        5. Other Therapies
      3. Middle East and Africa Autoinjectors Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Ambulatory Surgical Centers
      4. UAE
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      5. Turkey
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      6. Saudi Arabia
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      7. South Africa
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      8. Egypt
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      9. Nigeria
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      10. Rest of MEA
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
    5. LATAM
      1. LATAM Autoinjectors Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
      2. LATAM Autoinjectors Market By Indication  2022-2034 (USD MILLION/ Units)
        1. Rheumatoid Arthritis
        2. Multiple Sclerosis
        3. Diabetes
        4. Anaphylaxis
        5. Other Therapies
      3. LATAM Autoinjectors Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Homecare Settings
        2. Hospitals & Clinics
        3. Ambulatory Surgical Centers
      4. Brazil
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      5. Mexico
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      6. Argentina
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      7. Chile
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      8. Colombia
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
      9. Rest of LATAM
        1. Disposable Autoinjectors
        2. Reusable Autoinjectors
        3. Rheumatoid Arthritis
        4. Multiple Sclerosis
        5. Diabetes
        6. Anaphylaxis
        7. Other Therapies
        8. Homecare Settings
        9. Hospitals & Clinics
        10. Ambulatory Surgical Centers
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.